Search

Results 61-70 of 189
Publication DateTitleAuthor(s)
20-Apr-2011Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1Van Loosdregt, J; Brunen, D; Fleskens, V; Pals, CEGM; Lam, EWF, et al
22-Aug-2011FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancerKaradedou, CT; Gomes, AR; Chen, J; Petkovic, M; Ho, KK, et al
17-Feb-2006The cyclin D1 proto-oncogene is sequestered in the cytoplasm of mammalian cancer cell linesAlao, JP; Gamble, SC; Stavropoulou, AV; Pomeranz, KM; Lam, EW-F, et al
3-Oct-2006Role of glycogen synthase kinase 3 beta (GSK3β) in mediating the cytotoxic effects of the histone deacetylase inhibitor trichostatin A (TSA) in MCF-7 breast cancer cellsAlao, JP; Stavropoulou, AV; Lam, EW-F; Coombes, RC
8-Mar-2010FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistanceMillour, J; Constantinidou, D; Stavropoulou, AV; Wilson, MSC; Myatt, SS, et al
27-Nov-2015Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al
4-Aug-2015LMTK3 represses tumor suppressor-like genes through chromatin remodeling in breast cancerXu, Y; Zhang, H; Van, TMN; Angelopoulos, N; Nunes, J, et al
1-Mar-2015Risk of Ovarian Cancer Relapse Score A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian CancerRizzuto, I; Stavraka, C; Chatterjee, J; Borley, J; Hopkins, TG, et al
1-Oct-2013Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerEccles, SA; Aboagye, EO; Ali, S; Anderson, AS; Armes, J, et al
19-Jan-2012Differential oestrogen receptor binding is associated with clinical outcome in breast cancerRoss-Innes, CS; Stark, R; Teschendorff, AE; Holmes, KA; Ali, HR, et al